Seroprevalence of turkey coronavirus in North American turkeys determined by a newly developed enzyme-linked immunosorbent assay based on recombinant antigen.

MLA

Gomaa, Maged H., et al. “Seroprevalence of Turkey Coronavirus in North American Turkeys Determined by a Newly Developed Enzyme-Linked Immunosorbent Assay Based on Recombinant Antigen.” Clinical and Vaccine Immunology : CVI, vol. 15, no. 12, Dec. 2008, pp. 1839–44. EBSCOhost, https://doi.org/10.1128/CVI.00319-08.

APA

Gomaa, M. H., Yoo, D., Ojkic, D., & Barta, J. R. (2008). Seroprevalence of turkey coronavirus in North American turkeys determined by a newly developed enzyme-linked immunosorbent assay based on recombinant antigen. Clinical and Vaccine Immunology : CVI, 15(12), 1839–1844. https://doi.org/10.1128/CVI.00319-08

Chicago

Gomaa, Maged H, Dongwan Yoo, Davor Ojkic, and John R Barta. 2008. “Seroprevalence of Turkey Coronavirus in North American Turkeys Determined by a Newly Developed Enzyme-Linked Immunosorbent Assay Based on Recombinant Antigen.” Clinical and Vaccine Immunology : CVI 15 (12): 1839–44. doi:10.1128/CVI.00319-08.